19
G.HARIPRASAD M.Sc.,(Med micro), M.phil., Lecturer in Microbiology Department of Microbiology Thoothukudi Govt. Medical College Thoothukudi

Bacillus anthracis

Embed Size (px)

DESCRIPTION

This presentation was created for Micro students!

Citation preview

Page 1: Bacillus anthracis

G.HARIPRASAD M.Sc.,(Med micro), M.phil.,Lecturer in Microbiology Department of Microbiology Thoothukudi Govt. Medical College Thoothukudi

Page 2: Bacillus anthracis

• Aerobic,

• Gram positive

• sporulating

• capsulated

• non-motile bacilli.

Cause of anthrax

BACILLUS ANTHRACIS

(GRAM STAIN)

Page 3: Bacillus anthracis

Resistance

• Vegetative forms are destroyed – 600C in 30min.

• Spore form – viable for years in soil

• Autoclaving – kills anthrax spores

• 4% KmNo4 in 15 mts - kills anthrax spores

• Susceptible to many antibiotics like pencillin etc.,

Page 4: Bacillus anthracis

ANTIGENS

Important antigen:

• Capsular antigen

Other antigens:Cell wall polysaccharide antigens Somatic protein antigens

Page 5: Bacillus anthracis

1. Polypeptide capsule – antiphagocytic2. Anthrax toxin

Multicomponent anthrax toxin Factor I – Edema factor Factor II – Protective factor Factor III – Lethal factor Toxin binds with susceptible cells

through factor II Factor I & III enters the cellFactor I – causes edema by rising cAMP levels.Factor III – Kills the cell finally.

Page 6: Bacillus anthracis

Pathogenesis• Animals get infection

rarely by contact with infected animals

• Ingestion of spores – very common.

• Infected animals – discharge more anthrax bacilli from mouth, nose & rectum – sporulation in soil – survive for years – source for other animal

Page 7: Bacillus anthracis

HUMAN ANTHRAX

• Accidental infection• Secondarily infected

from diseased animal• Three clinical types - Cutaneous anthrax –

most common - Pulmonary anthrax –

less common - Intestinal anthrax – very

rare

Page 8: Bacillus anthracis

CUTANEOUS ANTHRAX• Spores enter thro’

abraded skin • Germinate & Multiply at

the site of entry.• Localised lesions - Face,

neck & hand.• Papule – vesicle –

pustular – centrally necrosed – black coloration.

Page 9: Bacillus anthracis
Page 10: Bacillus anthracis

PULMONARY ANTHRAX

• Inhalation of the dust or Inhalation of the dust or filaments of wool from filaments of wool from infected animals, infected animals, particularly in wool particularly in wool factories ( wool sorter’s factories ( wool sorter’s disease)disease)

• Haemotogenous spread Haemotogenous spread – 50% meningitis– 50% meningitis

Page 11: Bacillus anthracis

INTESTINAL ANTHRAX

• Consumption of improperly cooked infected meat.

• Causes violent enteritis with bloody diarrhoea

All clinical conditions lead to septicaemic anthrax if not treated early – Highly fatal!!!

Page 12: Bacillus anthracis

Laboratory diagnosis

• Pus from pustules – cutaneous anthrax

• Sputum – pulmonary anthrax

• Stool / suspected food – intestinal anthrax

• Blood – septicaemic anthrax

Page 13: Bacillus anthracis

Microscopy • Gram stain – for

bacilli demonstration • McFadyean’s

reaction – for capsule demonstration.

• Spore staining – for spore demonstration.

Gram stain

McFadyaen’s reaction

Spore stain

Page 14: Bacillus anthracis

SELECTIVE MEDIA – PLET MEDIUM –POLYMYXIN, LYSOZYME, EDTA & THALLOUS ACETATE

Culture

Page 15: Bacillus anthracis

Culture

• Other non-selective media

• Nutrient agar – colonies – medusa head appearance on low power microscopy

• Blood agar – usually non-haemolytic

Page 16: Bacillus anthracis

Gelatin liquefaction

Maximum liquefaction on the surface than at the bottom

INVERTED FIR TREE APPEARANCE

Page 17: Bacillus anthracis

Nitrate reduction test

Nitrate negative Nitrate positive

Page 18: Bacillus anthracis

ANIMAL INOCULATION

• Mouse/ guinea pigs are injected with specimens.

• Animal dies in 48 hrs

• Examine bacilli in blood of dead animal.

Page 19: Bacillus anthracis

TREATMENT

• Pencillin

• Erythromycin

• Antitoxins – in emergency cases

ANIMAL VACCINE – Sterne vaccine HUMAN VACCINE – Alum Precipitated Toxoid – 3 doses intramuscularly at intervals of 6 weeks and 6 months Booster dose after one year.